These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12470218)

  • 1. Post-translational modifications in prion proteins.
    Otvos L; Cudic M
    Curr Protein Pept Sci; 2002 Dec; 3(6):643-52. PubMed ID: 12470218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of post-translational modifications on prion protein aggregation and the propagation of scrapie-like characteristics in vitro.
    Dear DV; Young DS; Kazlauskaite J; Meersman F; Oxley D; Webster J; Pinheiro TJ; Gill AC; Bronstein I; Lowe CR
    Biochim Biophys Acta; 2007 Jul; 1774(7):792-802. PubMed ID: 17572162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cell-surface prion protein relative to its recombinant analogue: insights from molecular dynamics simulations of diglycosylated, membrane-bound human prion protein.
    DeMarco ML; Daggett V
    J Neurochem; 2009 Apr; 109(1):60-73. PubMed ID: 19226372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular prion proteins in human platelets show a phenotype different to those in brain tissues.
    Kuczius T; Kleinert J; Karch H; Sibrowski W; Kelsch R
    J Cell Biochem; 2011 Mar; 112(3):954-62. PubMed ID: 21328470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion propagation in cells expressing PrP glycosylation mutants.
    Salamat MK; Dron M; Chapuis J; Langevin C; Laude H
    J Virol; 2011 Apr; 85(7):3077-85. PubMed ID: 21248032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation.
    Taraboulos A; Rogers M; Borchelt DR; McKinley MP; Scott M; Serban D; Prusiner SB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8262-6. PubMed ID: 1978322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asparagine-linked glycosylation of the scrapie and cellular prion proteins.
    Haraguchi T; Fisher S; Olofsson S; Endo T; Groth D; Tarentino A; Borchelt DR; Teplow D; Hood L; Burlingame A
    Arch Biochem Biophys; 1989 Oct; 274(1):1-13. PubMed ID: 2505674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
    Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
    EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quiescin-sulfhydryl oxidase inhibits prion formation
    Zhan YA; Abskharon R; Li Y; Yuan J; Zeng L; Dang J; Martinez MC; Wang Z; Mikol J; Lehmann S; Bu S; Steyaert J; Cui L; Petersen RB; Kong Q; Wang GX; Wohlkonig A; Zou WQ
    Aging (Albany NY); 2016 Dec; 8(12):3419-3429. PubMed ID: 27959866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metal binding on solubility and resistance of physiological prions depend on tissues and glycotypes.
    Kuczius T; Kelsch R
    J Cell Biochem; 2013 Dec; 114(12):2690-8. PubMed ID: 23794222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational conversion of prion protein in prion diseases.
    Zhou Z; Xiao G
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein glycosylation is not required for strain-specific neurotropism.
    Piro JR; Harris BT; Nishina K; Soto C; Morales R; Rees JR; Supattapone S
    J Virol; 2009 Jun; 83(11):5321-8. PubMed ID: 19297485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.
    Capellari S; Parchi P; Russo CM; Sanford J; Sy MS; Gambetti P; Petersen RB
    Am J Pathol; 2000 Aug; 157(2):613-22. PubMed ID: 10934164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the glycosylation pattern of prion protein in murine scrapie. Implications for the mechanism of neurodegeneration in prion diseases.
    Russelakis-Carneiro M; Saborio GP; Anderes L; Soto C
    J Biol Chem; 2002 Sep; 277(39):36872-7. PubMed ID: 12130636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression and characterization of a glycosylated covalently linked dimer of the prion protein.
    Riley ML; Leucht C; Gauczynski S; Hundt C; Brecelj M; Dodson G; Weiss S
    Protein Eng; 2002 Jun; 15(6):529-36. PubMed ID: 12082172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.